Profile
Founded in 2012, Medivate is one of the first private equity firms in Korea with the expertise in value investing cross-border life sciences industry. Medivate has been raised ~$80 million capital into 5 portfolio companies which include clinical stage biotech companies and contract development manufacturing organizations (CDMOs). Medivate’s management team has proven record in life sciences industry provides competitive advantage by leveraging strategic partnership with the portfolio companies, a key to the successful investment returns.
Industry
Region of investment
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!
FAQs about Medivate Partners LLC
Where is Medivate Partners LLC located?
Medivate Partners LLC is located in South Korea.
When was Medivate Partners LLC founded?
Medivate Partners LLC was founded in 2012.
What sectors and industries does Medivate Partners LLC invest in?
Medivate Partners LLC invests in companies and startups in Healthcare Services, Biotechnology, Medical Devices, Pharmaceuticals, MedTech, Life Sciences.
What is Medivate Partners LLC geographical focus of investments?
Medivate Partners LLC invests in companies and startups in Asia.
At what stages of companies and startups does Medivate Partners LLC typically invest in?
Medivate Partners LLC invests in companies and startups at Series B.
What is the usual amount of Medivate Partners LLC investment?
Medivate Partners LLC usually invests $10-50 m on average.
What is the amount of assets of under management (AUM) for Medivate Partners LLC?
Medivate Partners LLC has around $80m assets under management.